10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Beta-lactam antibiotics represent a crucial class of antimicrobials renowned for their efficacy in combating bacterial infections. This group includes penicillins, cephalosporins, carbapenems, and monobactams, all sharing a common beta-lactam ring structure. Mechanistically, these antibiotics target bacterial cell walls by inhibiting enzymes involved in peptidoglycan synthesis. Penicillins, the pioneering members of this class, exert their antimicrobial action by binding to penicillin-binding proteins (PBPs), disrupting cell wall formation, and inducing bacterial lysis. Cephalosporins, displaying a broader spectrum, act similarly by interfering with cell wall synthesis but offer resistance against certain beta-lactamases.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : A rare case report: Hepatitis due to Chlamydia trachomatis infection in a 50 year old male patient
Eszter Tothne Karip, Maitland Hospital, Australia
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States